131 related articles for article (PubMed ID: 36758233)
1. Deformable registration with intensity correction for CESM monitoring response to Neoadjuvant Chemotherapy.
Jailin C; Milioni De Carvalho P; Mohamed S; Vancamberg L; Amr Farouk Ibrahim M; Gomaa MM; Kamal RM; Muller S
Biomed Phys Eng Express; 2023 Mar; 9(3):. PubMed ID: 36758233
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer.
Steinhof-Radwańska K; Grażyńska A; Lorek A; Gisterek I; Barczyk-Gutowska A; Bobola A; Okas K; Lelek Z; Morawska I; Potoczny J; Niemiec P; Szyluk K
Curr Oncol; 2021 Sep; 28(5):3448-3462. PubMed ID: 34590596
[TBL] [Abstract][Full Text] [Related]
4. Angiomammography: A review of current evidences.
Dromain C; Vietti-Violi N; Meuwly JY
Diagn Interv Imaging; 2019 Oct; 100(10):593-605. PubMed ID: 30962168
[TBL] [Abstract][Full Text] [Related]
5. Contrast Enhanced Spectral Mammography: A Review.
Patel BK; Lobbes MBI; Lewin J
Semin Ultrasound CT MR; 2018 Feb; 39(1):70-79. PubMed ID: 29317041
[TBL] [Abstract][Full Text] [Related]
6. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
[TBL] [Abstract][Full Text] [Related]
7. Practical uses of contrast-enhanced spectral mammography in daily work: A pictorial review.
Alexander S; Dulku G; Hashoul S; Taylor DB
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):473-478. PubMed ID: 31332941
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
[TBL] [Abstract][Full Text] [Related]
9. Quantification of enhancement in contrast-enhanced spectral mammography using a custom-made quantifier tool (I-STRIP): A proof-of-concept study.
Lobbes MBI; Mulder HKP; Rousch M; Backes WH; Wildberger JE; Jeukens CRLPN
Eur J Radiol; 2018 Sep; 106():114-121. PubMed ID: 30150032
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
Mao N; Shi Y; Lian C; Wang Z; Zhang K; Xie H; Zhang H; Chen Q; Cheng G; Xu C; Dai Y
Eur Radiol; 2022 May; 32(5):3207-3219. PubMed ID: 35066632
[TBL] [Abstract][Full Text] [Related]
11. Deformable registration for quantifying longitudinal tumor changes during neoadjuvant chemotherapy.
Ou Y; Weinstein SP; Conant EF; Englander S; Da X; Gaonkar B; Hsieh MK; Rosen M; DeMichele A; Davatzikos C; Kontos D
Magn Reson Med; 2015 Jun; 73(6):2343-56. PubMed ID: 25046843
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced spectral mammography in patients with MRI contraindications.
Richter V; Hatterman V; Preibsch H; Bahrs SD; Hahn M; Nikolaou K; Wiesinger B
Acta Radiol; 2018 Jul; 59(7):798-805. PubMed ID: 29058963
[TBL] [Abstract][Full Text] [Related]
13. Multiview multimodal network for breast cancer diagnosis in contrast-enhanced spectral mammography images.
Song J; Zheng Y; Zakir Ullah M; Wang J; Jiang Y; Xu C; Zou Z; Ding G
Int J Comput Assist Radiol Surg; 2021 Jun; 16(6):979-988. PubMed ID: 33966155
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced spectral mammography with a compact synchrotron source.
Heck L; Dierolf M; Jud C; Eggl E; Sellerer T; Mechlem K; Günther B; Achterhold K; Gleich B; Metz S; Pfeiffer D; Kröninger K; Herzen J
PLoS One; 2019; 14(10):e0222816. PubMed ID: 31600236
[TBL] [Abstract][Full Text] [Related]
16. Computer-aided diagnosis of contrast-enhanced spectral mammography: A feasibility study.
Patel BK; Ranjbar S; Wu T; Pockaj BA; Li J; Zhang N; Lobbes M; Zhang B; Mitchell JR
Eur J Radiol; 2018 Jan; 98():207-213. PubMed ID: 29279165
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of contrast enhanced spectral mammography grey value for early prediction of pathological response of breast cancer to neoadjuvant chemotherapy.
Xing D; Mao N; Dong J; Ma H; Chen Q; Lv Y
Sci Rep; 2021 Mar; 11(1):5892. PubMed ID: 33723322
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Enhancement Intensity in Contrast Enhancement Spectral Mammography and Types of Kinetic Curves in Magnetic Resonance Imaging.
Rudnicki W; Heinze S; Piegza T; Pawlak M; Kojs Z; Łuczyńska E
Med Sci Monit; 2020 Mar; 26():e920742. PubMed ID: 32173716
[TBL] [Abstract][Full Text] [Related]
19. Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts.
Lu Z; Hao C; Pan Y; Mao N; Wang X; Yin X
Korean J Radiol; 2020 Apr; 21(4):442-449. PubMed ID: 32193892
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
